Clinical Trial - Trial jRCT2031230257
Access comprehensive clinical trial information for jRCT2031230257 through Pure Global AI's free database. This phase not specified trial is sponsored by ABIVAX S.A. and is currently Recruiting. The study focuses on Ulcerative colitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031230257
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031230257
Untitled Trial
A randomized, double blind, multicenter phase III study to evaluate the long term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis.
Study Focus
Interventional
Sponsor & Location
ABIVAX S.A.
Argentina;Australia;Austria;Belgium;Bulgaria;Brazil;Canada;China;Czech;France;Germany;Greece;Hungary
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Ulcerative colitis
Other ulcerative colitis
Ulcerative colitis, unspecified
Arthropathy in ulcerative colitis
Juvenile arthritis in ulcerative colitis
Data Source
Japan Registry Clinical Trial
jRCT2031230257
Non-Device Trial